Vitals Today
  • Breaking News
  • Health
  • Policy
  • Studies
  • Companies
  • Professionals
  • Español
    • English
    • Español
No Result
View All Results
Vitals Today
  • Breaking News
  • Health
  • Policy
  • Studies
  • Companies
  • Professionals
  • Español
    • English
    • Español
No Result
View All Results
Vitals Today
No Result
View All Results

Studies » Tuberculosis is once again the leading cause of death from infections, according to WHO

Tuberculosis is once again the leading cause of death from infections, according to WHO

The WHO reveals that in 2023 tuberculosis has seen an alarming increase in its diagnoses, reaching 8.2 million new cases and re-emerging as the main cause of death from infectious diseases, surpassing Covid-19.

by Wendy Lazcano
December 11, 2024
Reading time: 3 mins read
Illustration of a human body with the lungs highlighted and a close-up of rod-shaped bacteria, representing pathogens.
Share on BlueskyShare on TwitterShare on Linkedin
  • Author
  • Recent Posts
Wendy Lazcano
Editor at Vitals Today
She is an experienced journalist who has worked in print media such as Diario de Cuba and Review Energy, as well as hosting radio (Wradio/Grupo PRISA) and television (Canal 33) programs. A specialist in politics and regulations, Wendy stands out for her ability to analyze and explain complex issues.
Latest posts by Wendy Lazcano (see all)
  • What is vortioxetine and what is this antidepressant prescribed for? - October 7, 2025
  • Ketoconazole Shampoo: How to Use It Correctly for Dandruff and Dermatitis? - October 6, 2025
  • What is the best time to take Hydroferol to absorb it better? - October 3, 2025

The World Health Organization (WHO) has announced in its most recent World tuberculosis report 2024 that Tuberculosis has re-emerged as the leading cause of infectious disease death in 2023, overtaking Covid-19. In 2023, 8.2 million new TB diagnoses were recorded, the highest number since global monitoring began in 1995. This increase represents a jump from the 7.5 million cases reported in 2022.

The report highlights that TB-related deaths decreased from 1.32 million in 2022 to 1.25 million in 2023. However, TB cases increased, reaching 10.8 million people in 2023. The burden of the disease remains concentrated in 30 countries. India, Indonesia, China, the Philippines and Pakistan account for 561% of global cases.

WHO Director-General Dr Tedros Adhanom Ghebreyesus stressed the need for action, saying: "It is a disgrace that so many people continue to die and become ill from tuberculosis, when we have the tools to prevent, detect and treat the disease."WHO calls on countries to honour their commitments to expand the use of these tools and end tuberculosis.

Persistent challenges according to the World Tuberculosis Report 2024

TB disproportionately affects men, who account for 551 TP3T of cases. Women and children/adolescents make up 331 TP3T and 121 TP3T, respectively. Although preventive treatment coverage was maintained for people living with HIV and improved for household contacts, multidrug-resistant tuberculosis (MDR/RR-TB) remains a problem. Treatment success rates for MDR/RR-TB reached 681 TP3T. However, only 441 TP3T of estimated cases received treatment in 2023.

Funding gap and economic challenges

WHO stressed that global funding to prevent and treat TB remains insufficient. In 2023, only $5.7 billion of the $22 billion needed annually was available, covering just 261 TP3T of the global target. The international contribution, led by the United States and the Global Fund, does not meet the demand of low- and middle-income countries, which bear 981 TP3T of the burden.

Impact on households and risk factors

For the first time, the WHO report estimates that half of households affected by TB face catastrophic costs to access diagnosis and treatment. Major risk factors for new cases include malnutrition, HIV infection, alcohol consumption, smoking and diabetes. Addressing these factors and poverty requires multisectoral coordination.

A call to global action

Dr Tereza Kasaeva, Director of WHO's Global Tuberculosis Programme, highlighted the multifaceted challenges:

We face multiple formidable challenges: funding gaps and catastrophic financial burden for affected people, climate change, conflict, migration and displacement, pandemics and drug-resistant tuberculosis, a major driver of antimicrobial resistance.

The WHO report calls for turning the commitments of the 2023 high-level meeting on tuberculosis into concrete actions. Increased funding for research, especially into new vaccines, is essential to achieving the goals set for 2027.

This report on tuberculosis reflects the WHO's growing concerns about global health crises, including the impact of climate change in public health

Tags: FeaturedInfectious DiseasesWHO
Previous Post

WHO approves new tests for detecting mpox

Next Post

New ELA Law in Spain: rights and improvements for patients and caregivers

Related Stories

A doctor with a stethoscope dressed in a white coat holds a bottle of medication in one hand and writes on a form with the other, while vials and a variety of pills lie on the table.
Health

Fluidasa: syrup, capsules, and what it's used for

July 11, 2025
A gloved hand holding a syringe as it is filled with liquid from a clear vial containing a pink liquid.
Health

Flumil: when to use it, how to administer it, and how it works

July 10, 2025
Panoramic view of the Second World Conference on Air Pollution and Health, with a lectern in the foreground and a large audience in the auditorium, where several flags and a screen presentation can be seen behind the speakers on stage.
Policy

More than 50 countries and cities make commitments to improve air quality

April 1, 2025
Colorful letters spelling out the words "MENTAL HEALTH" on a white fabric background.
Policy

WHO urges a transformation in mental health policies

March 27, 2025
Load More

Most Shared

  • A person holds a blue injection device in their hands, with an additional cartridge and several disposable needles on a wooden table.

    Ozempic in Spain: How much does it cost and how to get it?

    2 shared
    Share 1 Tweet 1
  • Mounjaro in Spain: When did it arrive and what's its price?

    4 shared
    Share 2 Tweet 1
  • Can I mix Enantyum and Paracetamol if the pain is very severe?

    2 shared
    Share 1 Tweet 1
  • Dexketoprofen vs. Ibuprofen: Which is better for pain?

    1 shared
    Share 0 Tweet 0
  • Can Ozempic be purchased without a prescription at pharmacies in Spain?

    0 shares
    Share 0 Tweet 0

logo for Vitals Today, your trusted source for health news, a green heart with the words Vitals Today, all in green

Vitals Today, your trusted source for healthcare news. Stay updated on the latest studies, regulations, and industry initiatives.

  • LinkedIn
  • X
  • Bluesky
  • About Us
  • Privacy Policy
  • Cookie Policy
  • Legal Notice
  • Contact

© 2024 Vitals Today - all rights reserved

Manage consent

To deliver the best experiences, we use technologies such as cookies to store and/or access device information. Accepting these technologies will allow us to process data such as browsing behavior or unique identifiers on this site. Not accepting or withdrawing consent may negatively impact certain features and functionality.

Functional Always active
Technical storage or access is strictly necessary for the legitimate purpose of allowing the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
Storage or technical access used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
Technical storage or access is necessary to create user profiles for the purpose of sending advertising, or to track the user on a website or across multiple websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}
No Result
View All Results
  • Portal
  • Breaking News
  • Policy
  • Studies
  • Companies
  • Professionals
  • Español
    • English
    • Español

© 2024 Vitals Today - all rights reserved